Using spleen size to help detect gastroesophageal varices in compensated cirrhosis
Official title: The Value of Spleen Thickness and Spleen Diameter for Gastroesophageal Varices Diagnosis in Compensated Cirrhosis
Run by Fifth Affiliated Hospital, Sun Yat-Sen University · NCT07920744 · Data updated 2026-11-12
This study tests whether ultrasound measurements of spleen size can help identify esophageal varices in adults with compensated cirrhosis, compared with the standard endoscopy test.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 364 (estimated) |
| Sponsor | Fifth Affiliated Hospital, Sun Yat-Sen University Academic / other |
| Locations | 1 site (Zhuhai, Guangdong) |
| Status | Recruiting |
| Started | October 28, 2026 |
| Main results expected | October 28, 2026 |
| Study ends | November 11, 2026 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07920744 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with compensated cirrhosis who have undergone both abdominal ultrasound and endoscopy within a six-month window.
✕Probably not a fit
Patients with decompensated cirrhosis, other liver or digestive system cancers, recent major treatments, or conditions that invalidate spleen and portal measurements may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a retrospective cross-sectional study that compares non-invasive ultrasound measurements of spleen thickness and spleen diameter to the invasive endoscopy results for detecting gastroesophageal varices and high-risk varices in patients with compensated cirrhosis. Researchers collected demographic, etiologic, and laboratory data along with imaging and endoscopy results to evaluate diagnostic performance. The analysis focuses on how well spleen size correlates with variceal presence and severity, potentially offering a non-invasive screening option. The study leverages data from patient records reviewed by senior infectious diseases and ultrasound physicians, with strict inclusion and exclusion criteria to define a stable compensated cirrhosis population.
Why it matters
Potential benefit: If successful, spleen measurements could provide a non-invasive screening option to identify patients who may need endoscopy.
How similar studies have gone: Previous work has explored non-invasive imaging markers for variceal risk, with mixed results, making this approach exploratory but promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years; 2. compensated cirrhosis; Exclusion Criteria: 1. history of hepatic decompensation, such as ascites, EVB, and hepatic encephalopathy; 2. non-cirrhotic portal hypertension; 3. digestive system malignancies such as hepatocellular carcinoma, pancreatic carcinoma, or other malignant tumors infiltrating the digestive system; 4. acute liver disease, or serum total bilirubin ≥ 100 μmol/L; 5. history of splenectomy; 6. acute or chronic portal vein thrombosis; 7. pregnancy; 8. concomitant HIV infection; 9. prior TIPS, endoscopic variceal ligation (EVL), or endoscopic injection sclerotherapy (EIS); 10. receipt of non-selective beta-blockers (NSBBs) or diuretics within 3 months before EGD or abdominal ultrasonography; 11. persistent drug abuse other than alcohol; 12. an interval of more than 6 months between abdominal ultrasonography and EGD, or the absence of results from either examination.
Where it's running
-
the Fifth Affiliated Hospital, Sun Yat-sen University
Zhuhai, Guangdong, China Recruiting
Study contacts
- Study coordinator: Xi Liu
- Email: liuxi26@mail.sysu.edu.cn
- Phone: 15992670630
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Laparoscopic liver and spleen removal for small liver cancer in people with cirrhosis and enlarged spleen
This study tests whether removing part of the liver and the spleen during one operation helps people with small liver cancers and hypersplenism by improving liver function and immune balance.
-
Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS
A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.
-
Foscenvivint in HIV/HCV co-infected adults with liver cirrhosis and hemophilia
This study tests whether foscenvivint can help people with liver cirrhosis due to HIV/HCV co-infection who also have hemophilia.
-
Austrian PBC Registry
This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.
-
Reference framework for outcomes after machine-preserved liver transplantation in Europe
This study tests how liver transplants that use machine perfusion perform in real-world practice, to see how different perfusion methods relate to outcomes for adults in Europe.
-
Even protein distribution plus exercise for people awaiting liver transplant
This trial tests whether spreading daily protein evenly and combining it with a 12-week exercise program improves nutrition, muscle mass, and function in people waiting for a liver transplant compared with uneven protein timing or usual advice.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.